Amsterdam institute for Immunology and Infectious diseases
AI&I news
Existing CRP Test Proves Effective for Faster Diagnosis of Bacterial MeningitisResearchers at Amsterdam UMC have shown that a widely used diagnostic tool—the C-reactive protein (CRP) test—can also be applied to cerebrospinal fluid (CSF) to quickly and accurately detect life-threatening bacterial meningitis. While CRP testing is already common in blood to identify inflammation and bacterial infections, its use in spinal fluid marks a significant and practical advancement.
Dr. Neeltje Kootstra appointed Professor of Immune Pathogenesis of Viral Infections and Interventions Dr. Neeltje Kootstra has been appointed as Professor of Immune Pathogenesis of Viral Infections and Interventions at Amsterdam UMC. Her chair is embedded within the Department of Experimental Immunology (EXIM), part of Division 9: Laboratories of Amsterdam UMC, and is affiliated with the Infectious Diseases program of the Amsterdam Institute for Immunology and Infectious Diseases (AI&I).
Proof of concept for Amsterdam UMC-led HIV vaccinationWorldwide, an estimated 40 million people live with HIV, two-thirds living on the African continent. In 2023, more than 600,000 people died from HIV-related causes and 1.32 million became infected. There is no vaccine against the world's second most deadly infection – only tuberculosis kills more people. However, researchers from Amsterdam UMC have taken an important step towards reaching the goal of an HIV vaccine. The results of their phase one trial are published today in Science.
